MVEIX | VMVAX | MVEIX / VMVAX | |
Total Expense Ratio | 1.47 | 0.07 | 2,100% |
Annual Report Gross Expense Ratio | 1.47 | 0.07 | 2,100% |
Fund Existence | 27 years | 14 years | - |
Gain YTD | 1.487 | -0.775 | -192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 3000 | 333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.1M | 29.1B | 0% |
Annual Yield % from dividends | 0.99 | 2.40 | 41% |
Returns for 1 year | -5.13 | 4.10 | -125% |
Returns for 3 years | 7.41 | 15.69 | 47% |
Returns for 5 years | 25.82 | 77.99 | 33% |
Returns for 10 years | -35.67 | 74.68 | -48% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FNGG | 176.49 | 1.57 | +0.90% |
Direxion Daily NYSE FANG+ Bull 2X Shares | |||
FVAL | 60.95 | N/A | N/A |
Fidelity Value Factor ETF | |||
MMCA | 21.04 | N/A | N/A |
NYLI MacKay California Muni Intmdt ETF | |||
SPEM | 41.47 | -0.12 | -0.29% |
SPDR® Portfolio Emerging Markets ETF | |||
QMOM | 60.50 | -0.28 | -0.46% |
Alpha Architect US Quantitative Momt ETF |